U.S. Wireless Telecom Stock News

With US inflation easing to 3.5% and gas prices pulling headline figures lower, investors are again weighing how persistent high living costs might affect essential spending. Consumer staples stocks sit at the center of that debate, as households still need food and household goods even when budgets feel tight. This article looks at 3 stocks from a Consumer Staples Stocks screener that appear closely exposed to the latest inflation news. Each company may react differently to easing price...

Ultragenyx Pharmaceutical (RARE) stock continues to trade with recent moves shaped largely by its rare disease portfolio and late stage pipeline. This has prompted investors to reassess risk, growth potential, and current valuation. See our latest analysis for Ultragenyx Pharmaceutical. At a share price of $29.28, Ultragenyx Pharmaceutical has seen short term pressure, with a 1 day share price return down 3.11% and 7 day share price return down 13.42%. This is set against a 90 day share price...

Apple (AAPL) is back in the spotlight after Chinese regulators cleared its Apple Intelligence services and HSBC upgraded the stock, a one two that coincided with Apple briefly overtaking Nvidia as the world’s most valuable company. See our latest analysis for Apple. For investors, the recent approvals for Apple Intelligence in China and the HSBC upgrade have arrived on top of strong momentum, with a 30 day share price return of 12.77% and a year to date share price return of 23.15%...

Dollar General stock has delivered a steep 40.3% decline over the past 5 years, yet current valuation checks and intrinsic value work both suggest the shares now trade at a discount to what the underlying business may be worth. Over 5 years, Dollar General shareholders are down 40.3%, which sets expectations for a potential reset in how the stock is priced relative to its fundamentals. Rising gas prices and household cost pressures can support revenue as consumers trade down to discount...

Haemonetics (HAE) has drawn attention after recent share price moves, including a gain of about 7% over the past month and roughly 26% over the past 3 months. These changes are prompting closer examination of its fundamentals. See our latest analysis for Haemonetics. At a share price of $77.86, Haemonetics shows recent momentum with a 30 day share price return of 7.05% and a 90 day share price return of 26.36%. This is set against a more modest 1 year total shareholder return of 7.32% and a 3...

SoFi Technologies stock has delivered an 83.2% gain over the past three years, yet the latest valuation work suggests the shares trade at a premium, with both the intrinsic value estimate from the Excess Returns model and the market multiples pointing to overvaluation. The 83.2% return over three years puts SoFi in the category of stocks that have already rewarded shareholders. This can leave less room for error if expectations change. Growth in SoFi's banking and broader financial services...

Partner trial for Darzalex Faspro using Halozyme's ENHANZE technology reported significant survival benefits for multiple myeloma patients. Late stage study results point to improved outcomes for people receiving this subcutaneous therapy. News is material for Halozyme Therapeutics (NasdaqGS:HALO) as it relates directly to one of its key partnered medicines. Halozyme Therapeutics centers its business on ENHANZE, a drug delivery technology licensed to large biopharma partners. The latest...

Hexcel (HXL) stock is drawing fresh attention after the company confirmed it will showcase its latest high performance composite materials and pursue new industry partnerships at the 2026 Farnborough International Airshow. See our latest analysis for Hexcel. The Farnborough announcement comes after a strong run in Hexcel’s stock, with a 16.96% 90 day share price return and a 73.23% 1 year total shareholder return signalling building momentum at the current US$103.81 share price. If Hexcel’s...

CareTrust REIT stock has delivered a strong 133.7% return over the past three years, yet its valuation checks paint a more measured picture, with signals that are positive but not uniformly compelling. Over the last three years, CareTrust REIT has returned 133.7%, which puts extra focus on whether the current share price already reflects much of that progress. For a healthcare focused REIT, the long term appeal of stable rental income can support the valuation, while any pressure on tenant...

Caterpillar (CAT) is back in focus after a recent comparison with SpaceX highlighted how its heavy equipment, autonomous technology, and software driven services fit into a more mature, cash generating business model. See our latest analysis for Caterpillar. At a share price of $880.28, Caterpillar has given investors a 47.10% year to date share price return and a 5 year total shareholder return of 357.00%. The 30 day share price return of 7.91% and 7 day share price return of 7.57% indicate...

Arch Capital Group (ACGL) has caught investors’ attention after a 9.7% stock return over the past month, coinciding with updated earnings estimates that point to a 5% year-over-year decline this quarter. See our latest analysis for Arch Capital Group. Looking beyond the past month, Arch Capital Group’s 1 year total shareholder return of 14.71% and 5 year total shareholder return of 176.62% sit alongside a 7.98% year to date share price return. This suggests momentum has been building despite...

Visteon (NasdaqGS:VC) has entered new multi year partnership agreements to secure advanced memory and storage supplies for automotive applications. The company is part of Micron's newly completed Strategic Customer Agreements alongside other major automotive suppliers and partners. The partnerships focus on long term supply and technology planning for next generation, AI enabled vehicle platforms. Visteon sits at the intersection of automotive electronics and software, supplying cockpit...

After several years where Clorox stock has fallen about 38% over 5 years, current valuation checks point in the opposite direction, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples suggesting the shares may now be pricing in relatively low expectations. The share price decline of roughly 38.2% over 5 years signals that investors have been marking Clorox down, even before considering today’s valuation signals. Expectations for pressured margins and softer...

Rare earth metal stocks sit at the crossroads of technology, defense, and the clean energy buildout. Today’s mixed global backdrop, from steady US bond yields to shifting industrial output in Asia and Europe, keeps attention firmly on supply security for these materials. With only a limited pool of companies focused on mining these critical elements, a targeted Rare Earth Metal Stocks screener can help you cut through market noise and focus on pure exposure to this theme. This article...

Earlier this month, the UK Ministry of Defence awarded Omnia Training a £2.00 billion, 15-year contract to become the British Army’s Strategic Training Partner, with a RaytheonUK-led consortium delivering a digitally enabled collective training system that blends virtual, synthetic and data-driven environments. This win underlines RTX’s deepening role in high-tech military training and synthetic environments, reinforcing its broader push into advanced defence technologies and integrated...

Huntington Bancshares (HBAN) is in focus after its subsidiary, Huntington Securities, launched an equity research platform in July 2026. The platform covers Real Estate Investment Trusts and Utilities for Huntington Capital Markets clients. See our latest analysis for Huntington Bancshares. At a share price of US$18.25, Huntington Bancshares has seen its 30 day share price return rise 8.31%, while the 1 year total shareholder return of 13.31% and very large 3 year total shareholder return...

Dycom Industries (DY) recently drew fresh attention after research coverage highlighted rising cash flows, stronger earnings estimates for fiscal 2027, and sector outperformance so far this year. This has prompted investors to reassess the stock’s risk reward profile. See our latest analysis for Dycom Industries. At a recent share price of $407.11, Dycom Industries has seen the share price fall over the past week and month, but still report a 17.13% year to date share price return and a very...

PVH (PVH) stock is back in focus after the company announced that Alexis Rollier will become Chief Financial Officer in early September 2026, succeeding interim CFO Melissa Stone. See our latest analysis for PVH. At a share price of US$78.15, PVH has eased in the very short term, with a 1 day share price return that declined 2.10% and a 90 day share price return that declined 17.01%. However, the year to date share price return is up 15.23% and the 1 year total shareholder return is 9.67%,...

With Federal Reserve officials turning more hawkish and inflation risks tied to energy and AI-driven demand back in focus, interest rate expectations are once again front and center for U.S. financial sector stocks. When borrowing costs move, large, financially resilient companies in banking, insurance, and other financial services can face very different outcomes depending on their balance sheets and business mix. This article explains how the latest Fed signals and inflation concerns...

Vicor (VICR) has moved into focus after booming AI data center demand, stronger backlog, guidance raises, and ongoing capacity expansion combined with rapid financial performance improvement to reset expectations around its stock. See our latest analysis for Vicor. Vicor’s share price has been volatile in the short term, with a 1 day share price return of 3.13% and a 30 day share price return down 26.92%, yet its year to date share price return of 103.34% and 1 year total shareholder return...

Natera (NTRA) stock is in focus after two key developments: a final local coverage determination expanding Prospera transplant test access and stronger than expected revenue growth supported by higher testing volumes. See our latest analysis for Natera. Natera’s recent developments appear to be reflected in its share price, with a 30.2% 90 day share price return and a very large 3 year total shareholder return that suggests momentum has been building over a longer period. If Natera’s move has...

Coca-Cola stock has delivered a 65.9% total return over the past five years, yet the latest valuation checks send mixed signals, with the intrinsic value estimate pointing to some upside while earnings-based multiples indicate the shares are priced at a premium. A 65.9% return over five years suggests Coca-Cola has already rewarded long-term holders, so fresh buyers may be asking how much value is left on the table. Strong pricing power that investors like Warren Buffett often highlight can...

How Eversource Energy Stock Has Been Performing Eversource Energy (ES) has been trading without a clear single news catalyst, so investors are focusing on how the stock has moved recently and how that lines up with its fundamentals. Over the past month, the stock has gained about 8%, and over the past 3 months it is up roughly 7.8%. Year to date, Eversource Energy shows a total return close to 9.6%, with the 1 year total return around 19.3%. On a longer view, the 3 year total return stands...

Aehr Test Systems reported past fourth-quarter 2026 results with sales of US$18.84 million and net income of US$1.39 million, while full-year 2026 sales fell to US$50.00 million alongside a net loss of US$7.13 million. Management highlighted a sharp shift in revenue mix toward AI processors, silicon photonics, and power semiconductors, backed by record bookings and an effective backlog above US$80.00 million. We’ll now examine how this AI-driven revenue guidance and expanding backlog shape...